Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 275 of 277 entries
View as:

Quality of Life in Patients With Clinically Localized Prostate Cancer Treated With Radiosurgery

Phase: N/A Priority: Normal
NCT ID: NCT01766492 Org: User:
Start: 12/31/12 End: 04/30/25 Due: 04/30/26

Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04499053 Org: User:
Start: 12/09/20 End: 12/31/27 Due: 12/31/28

TALAVE: Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03964532 Org: User:
Start: 04/17/19 End: 03/31/26 Due: 03/31/27

ActiV.A.C.+ Compression Therapy Versus Compression Therapy Alone for the Treatment of Chronic Venous Ulcerations

Phase: N/A Priority: Normal
NCT ID: NCT01528293 Org: User:
Start: 07/31/12 End: 03/31/14 Due: 03/31/15

Exemestane and Celecoxib in Postmenopausal Women at High Risk for Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00073073 Org: User:
Start: 11/30/03 End: 12/31/11 Due: 12/31/12

A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06248515 Org: User:
Start: 04/25/24 End: 12/31/26 Due: 12/31/27

Phase IB/II of CPX-351 for Relapse Prevention in AML

Phase: N/A Priority: Normal
NCT ID: NCT04990102 Org: User:
Start: 05/22/23 End: 08/31/25 Due: 08/31/26

The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI

Phase: N/A Priority: Normal
NCT ID: NCT06892275 Org: User:
Start: 05/31/25 End: 12/31/27 Due: 12/31/28

Genetic Counseling in Women at Risk for BRCA1 or BRCA2 Mutations

Phase: N/A Priority: Normal
NCT ID: NCT00416754 Org: User:
Start: 12/31/00 End: 12/31/06 Due: 12/31/07

Role of a CCK Receptor Antagonist Proglumide in Management of Chronic Pancreatitis

Phase: N/A Priority: Normal
NCT ID: NCT05551858 Org: User:
Start: 11/17/22 End: 12/31/26 Due: 12/31/27

Impact of Two Methods of Listening to Music During Exercise on Perceived Exertion and Overall Physical Activity

Phase: N/A Priority: Normal
NCT ID: NCT00804700 Org: User:
Start: 12/31/08 End: 06/30/09 Due: 06/30/10

Study Using Pharmacogenetics to Select Treatment for Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00881114 Org: User:
Start: 04/30/09 End: 06/30/13 Due: 06/30/14

Ofatumumab and Bendamustine for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Phase: N/A Priority: Normal
NCT ID: NCT01010568 Org: User:
Start: 04/30/10 End: 08/31/14 Due: 08/31/15

Enhance the Use of Genetic Counseling and Testing in Latinas

Phase: N/A Priority: Normal
NCT ID: NCT04544501 Org: User:
Start: 02/24/20 End: 01/31/22 Due: 01/31/23

NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04005339 Org: User:
Start: 07/29/19 End: 12/31/25 Due: 12/31/26

Exercise in Gulf War Illness (GWI)

Phase: N/A Priority: Normal
NCT ID: NCT01291758 Org: User:
Start: 07/31/09 End: 09/30/12 Due: 09/30/13

Study of Gemcitabine and Abraxane for Pancreas Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02242409 Org: User:
Start: 09/30/14 End: 12/31/16 Due: 12/31/17

Predictors of Adjuvant Endocrine Therapy in Women With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02992730 Org: User:
Start: 04/30/11 End: 12/31/19 Due: 12/31/20

Impact Evaluation of Community-Based Health Programs in Rwanda

Phase: N/A Priority: Normal
NCT ID: NCT01836731 Org: User:
Start: 04/30/13 End: 06/30/17 Due: 06/30/18

Brain-based Understanding of Individual Language Differences After Stroke

Phase: N/A Priority: Normal
NCT ID: NCT04991519 Org: User:
Start: 11/01/18 End: 08/30/28 Due: 08/30/29

Nilotinib in Cognitively Impaired Parkinson Disease Patients 001

Phase: N/A Priority: Normal
NCT ID: NCT02281474 Org: User:
Start: 11/30/14 End: - Due: -

Connect to Baby: A Pilot Study of a Parenting and Coparenting Program

Phase: N/A Priority: Normal
NCT ID: NCT06179576 Org: User:
Start: 08/01/23 End: 12/31/24 Due: 12/31/25

Investigation of a Novel Wound Gel to Improve Wound Healing in Chronic Wounds

Phase: N/A Priority: Normal
NCT ID: NCT03686904 Org: User:
Start: 11/19/18 End: 02/14/20 Due: 02/14/21

Safety and Tolerability of Oral Proglumide for NASH

Phase: N/A Priority: Normal
NCT ID: NCT04152473 Org: User:
Start: 12/13/19 End: 09/09/22 Due: 09/09/23

A Phase I/II Study of Ganetespib in Combination With Doxorubicin

Phase: N/A Priority: Normal
NCT ID: NCT02261805 Org: User:
Start: 10/31/14 End: 10/31/16 Due: 10/31/17